Sunshine Biopharma, Inc. (SBFM)
USD 2.75
(0.37%)
USD 2.75
(0.37%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -8.77 Million | -5.24 Million | -1.82 Million | -657.29 Thousand | -495.79 Thousand | -512.8 Thousand |
| Net Income | -4.5 Million | -26.74 Million | -12.43 Million | -2.78 Million | -1.66 Million | -2.15 Million |
| Depreciation & Amortization | 149.14 Thousand | 25.16 Thousand | 12.74 Thousand | 14.06 Thousand | 13.77 Thousand | 49.36 Thousand |
| Deferred income taxes | - | 3628.00 | -918 Thousand | -50 Thousand | -261.68 Thousand | - |
| Stock-based compensation | - | - | 918 Thousand | 50 Thousand | 261.68 Thousand | 676.1 Thousand |
| Change in working capital | -4.41 Million | 3.15 Million | -108.79 Thousand | -42.63 Thousand | -30.92 Thousand | 54.58 Thousand |
| Other non-cash items | 4.62 Million | 18.31 Million | 10.7 Million | 2.15 Million | 1.18 Million | 1.53 Million |
| Investing Cash Flow | -656.15 Thousand | -14.61 Million | - | -1191.00 | -15.27 Thousand | -13.9 Thousand |
| Investments in PPE | -788.09 Thousand | -304.99 Thousand | - | -1191.00 | -860.00 | -18.85 Thousand |
| Acquisitions | 131.94 Thousand | -14.34 Million | - | - | - | 4942.00 |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -573.89 Thousand | 33.37 Thousand | - | - | -14.41 Thousand | - |
| Financing Cash Flow | 3.42 Million | 39.46 Million | 2.9 Million | 1.6 Million | 442.25 Thousand | 527.64 Thousand |
| Debt repayment | -125.98 Thousand | -3.99 Million | -475.32 Thousand | -106.6 Thousand | -53 Thousand | -194.18 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -541.14 Thousand | -99 Thousand | - | - | - | - |
| Common Stock Issuance | 4.09 Million | 30.36 Million | - | - | - | - |
| Other Financing Activities | -125.99 Thousand | 13.19 Million | 3.38 Million | 1.71 Million | 495.25 Thousand | 721.82 Thousand |
| Accounts receivables | -594.14 Thousand | -524.48 Thousand | -5882.00 | -1486.00 | -430.00 | -15.44 Thousand |
| Accounts payables | -1.36 Million | 3.35 Million | -18.15 Thousand | -35.01 Thousand | -18.69 Thousand | 61.62 Thousand |
| Inventory | -2.36 Million | 42.98 Thousand | -81.87 Thousand | -7861.00 | -15.91 Thousand | - |
| Other working capital | -94.39 Thousand | 276.86 Thousand | -2880.00 | 1720.00 | 4110.00 | 8402.00 |
| Cash at beginning of period | 21.82 Million | 2.04 Million | 989.88 Thousand | 40.5 Thousand | 115.21 Thousand | 107.53 Thousand |
| Cash at end of period | 16.29 Million | 21.82 Million | 2.04 Million | 989.88 Thousand | 40.5 Thousand | 115.21 Thousand |
| Capital Expenditure | -788.09 Thousand | -304.99 Thousand | - | -1191.00 | -860.00 | -18.85 Thousand |
| Effect of forex changes on cash | 471.58 Thousand | 183.91 Thousand | -20.26 Thousand | -376.00 | -5896.00 | 6758.00 |
| Net cash flow / Change in cash | -5.53 Million | 19.78 Million | 1.05 Million | 949.38 Thousand | -74.71 Thousand | 7684.00 |
| Free Cash Flow | -9.56 Million | -5.55 Million | -1.82 Million | -658.49 Thousand | -496.65 Thousand | -531.65 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -494.3 Thousand | -1.28 Million | -1.25 Million | -4.5 Million | -651.48 Thousand | -902.1 Thousand |
| Depreciation & Amortization | 50.87 Thousand | 42.61 Thousand | 42.35 Thousand | 149.14 Thousand | 37.2 Thousand | 34.88 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | 12 Thousand | - | - | - | - |
| Change in working capital | -4.13 Million | -1.95 Million | -1.48 Million | -4.41 Million | 157.36 Thousand | -2.91 Million |
| Other non-cash items | 780.6 Thousand | 1.44 Million | 377.00 | 4.62 Million | -374.00 | 1.75 Million |
| Investing Cash Flow | -542.2 Thousand | -668.73 Thousand | -269.23 Thousand | -656.15 Thousand | 18.85 Thousand | -259.47 Thousand |
| Investments in PPE | -572.21 Thousand | -699.8 Thousand | -303.68 Thousand | -788.09 Thousand | -11.79 Thousand | -294.23 Thousand |
| Acquisitions | 30 Thousand | 31.06 Thousand | 34.45 Thousand | 131.94 Thousand | 30.65 Thousand | 67.68 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 1.00 | -605.79 Thousand | -651.59 Thousand | -573.89 Thousand | 28.49 Thousand | -32.93 Thousand |
| Financing Cash Flow | -28.58 Thousand | 5.39 Million | -30.51 Thousand | 3.42 Million | -63.56 Thousand | 4.05 Million |
| Debt repayment | -28.58 Thousand | -29.61 Thousand | -93.12 Thousand | -125.98 Thousand | -29.25 Thousand | -32.39 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -3.13 Million | 541.14 Thousand | -541.14 Thousand | -34.32 Thousand | - |
| Common Stock Issuance | - | 8.56 Million | 2346.00 | 4.09 Million | 10.00 | 4.08 Million |
| Other Financing Activities | -28.58 Thousand | -29.61 Thousand | 93.12 Thousand | -125.99 Thousand | 29.25 Thousand | 1156.00 |
| Accounts receivables | -1.33 Million | -536.26 Thousand | -475.65 Thousand | -594.14 Thousand | -63.32 Thousand | -191.05 Thousand |
| Accounts payables | 1.5 Million | 1.29 Million | -776.16 Thousand | -1.36 Million | 515.52 Thousand | -1.02 Million |
| Inventory | -848.84 Thousand | -2.1 Million | -1.14 Million | -2.36 Million | -335.86 Thousand | -467.92 Thousand |
| Other working capital | -3.45 Million | -612.8 Thousand | 913.87 Thousand | -94.39 Thousand | 41.02 Thousand | -1.22 Million |
| Cash at beginning of period | 17.43 Million | 16.29 Million | 18.84 Million | 21.82 Million | 19.72 Million | 19.29 Million |
| Cash at end of period | 11.5 Million | 17.43 Million | 16.29 Million | 16.29 Million | 18.84 Million | 19.72 Million |
| Capital Expenditure | -572.21 Thousand | -699.8 Thousand | -303.68 Thousand | -788.09 Thousand | -11.79 Thousand | -294.23 Thousand |
| Effect of forex changes on cash | -777.88 Thousand | -402.39 Thousand | 435.63 Thousand | 471.58 Thousand | -381.35 Thousand | 414.81 Thousand |
| Net cash flow / Change in cash | -5.92 Million | 1.14 Million | -2.55 Million | -5.53 Million | -883.35 Thousand | 435.27 Thousand |
| Free Cash Flow | -5.15 Million | -3.88 Million | -2.99 Million | -9.56 Million | -469.08 Thousand | -4.07 Million |
7164
BJTRF
5236
GRYRF
BWB
BAJAJHCARE